Search Results
Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the US
Imugene + Celularity Announce an Exclusive Strategic Partnership to Develop a Novel Oncolytic Virus.
Investor Presentation post ASX news: Imugene and Eureka Therapeutics onCARlytics Collaboration
Imugene's Science Series featuring the Oncolytic Viraltherapy CHECKvacc
Imugene (ASX:IMU) | Webinar with Leslie Chong | 07/11/24
Imugene Investor Webinar: MAST Study Update
Imugene Investor Webinar | FDA IND Clearance for onCARlytics
Imugene growing by leaps and bounds while advancing novel technology platforms
VAXXED: Deadly infection, with Imugene and ImmVirX
ImmVirX Interim Chair & CEO Dr Malcolm McColl presentation from the NWR Virtual Healthcare Day.
NCIS ISOS 2021 - Gene Therapy Using Oncolytic Virus for Cancer-recent Advances
Can Viruses Help Treat Cancer?
